Efficacy of biosilicate glass-ceramic and gluma in the treatment of cervical dentin hypersensitivity: an interim results of randomised control trial

dc.creatorMaria Luiza Lima Santana
dc.creatorAna Isis Cesário
dc.creatorDanilo Rocha Dias
dc.creatorEdgar Dutra Zanotto
dc.creatorOscar Peitl Filho
dc.creatorCarlos Estrela
dc.creatorVirgílio Moreira Roriz
dc.date.accessioned2024-07-16T16:00:03Z
dc.date.accessioned2025-09-09T01:26:29Z
dc.date.available2024-07-16T16:00:03Z
dc.date.issued2022-04
dc.format.mimetypepdf
dc.identifier.doi10.7860/JCDR/2022/52874.16269
dc.identifier.issn2249-782X
dc.identifier.urihttps://hdl.handle.net/1843/70772
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.relation.ispartofJournal of Clinical and Diagnostic Research
dc.rightsAcesso Aberto
dc.subjectOdontologia
dc.subjectSensibilidade da Dentina
dc.subjectMedição da Dor
dc.subjectDessensibilizantes Dentinários
dc.subject.otherDentin hypersensitivity
dc.subject.otherTreatment
dc.subject.otherDentin desensitizing agents
dc.titleEfficacy of biosilicate glass-ceramic and gluma in the treatment of cervical dentin hypersensitivity: an interim results of randomised control trial
dc.typeArtigo de periódico
local.citation.epage54
local.citation.issue4
local.citation.spage51
local.citation.volume16
local.description.resumoIntroduction: Dentin Hypersensitivity (DH) is known to be a relatively common condition that affects a considerable portion of the population, and manifests itself in the form of acute pain, due to the exposure of dentin and open dentinal tubules, after the removal of enamel or root cement. It has a multifactorial aetiology. Aim: To compare the efficacy in DH treatment using Biosilicate and Gluma Desensitiser. Materials and Methods: This randomised clinical trial pilot study with a split-mouth design included seven participants. Two teeth presenting Gingival Recession (GR)-related DH were selected in each participant and allocated to treatment groups by simple randomisation. Gluma® desensitiser (GD) and Biosilicate® (BIO) were applied once a week for four weeks. The pain intensity under a volatile stimulus was measured using a Visual Analogue Scale (VAS) at baseline and after treatment, at 15 days and 6 months follow-up. Data analysis were performed by means of descriptive statistics, Paired t-test for inter-group comparison and Friedman test for intra-group comparison (p-value <0.05). Results: The mean age of seven participants were 19.9 years, from which five were women (71.4%). The GD and BIO groups presented initial mean VAS values of 4.86±2.55 and 6.14±1.57, respectively. Fifteen days after treatment, both groups showed a significant improvement (GD group p-value=0.03 and BIO group p-value=0.02, Wilcoxon test) in pain intensity, with 71.4% teeth without sensitivity (VAS=0). Conclusion: Both treatments resulted in a reduction in painful sensitivity under volatile stimuli 15 days after treatment. BIO group presented a better outcome regarding reduction in DH, without recurrence at the 6th month evaluation, when compared to GD group.
local.publisher.countryBrasil
local.publisher.departmentFAO - DEPARTAMENTO DE ODONTOLOGIA RESTAURADORA
local.publisher.initialsUFMG
local.url.externahttps://jcdr.net/article_abstract.asp?issn=0973-709x&year=2022&volume=16&issue=4&page=ZC51&issn=0973-709x&id=16269

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
Efficacy of Biosilicate Glass-Ceramic and Gluma in the Treatment of Cervical Dentin Hypersensitivity- An Interim Results of Randomised Control Trial.pdf
Tamanho:
311.54 KB
Formato:
Adobe Portable Document Format

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
License.txt
Tamanho:
1.99 KB
Formato:
Plain Text
Descrição: